Development of an Allogeneic TAC Gamma Delta T Cell Immunotherapy Program

Time: 12:30 pm
day: Day Two

Details:

  • Donor screening and selection
  • Assay development and qualification
  • Manufacturing for Phase I Clinical Studies

Speakers: